×
News Home

Should You Buy Talis Biomedical Corp (TLIS) Stock After it Has Gained 29.87% in a Week?

Wednesday, August 17, 2022 03:36 PM | InvestorsObserver Analysts
Should You Buy Talis Biomedical Corp (TLIS) Stock After it Has Gained 29.87% in a Week?

Talis Biomedical Corp (TLIS) stock has risen 29.87% over the past week and gets a Bullish rating from InvestorsObserver Sentiment Indicator.

Sentiment Score - ,bullish
Talis Biomedical Corp has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on TLIS!

What is Stock Sentiment?

Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score. As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend. Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish. InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion. For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.

What's Happening With TLIS Stock Today?

Talis Biomedical Corp (TLIS) stock has gained 19.6% while the S&P 500 has fallen -0.57% as of 3:35 PM on Wednesday, Aug 17. TLIS has gained $0.16 from the previous closing price of $0.84 on volume of 2,197,196 shares. Over the past year the S&P 500 is lower by -4.44% while TLIS has fallen -87.01%. TLIS lost -$4.64 per share in the over the last 12 months. To screen for more stocks like Talis Biomedical Corp click here.

More About Talis Biomedical Corp

Talis Biomedical Corp is engaged in developing and commercializing products designed to enable molecular testing for infectious diseases and other conditions at the point-of-care. Its Talis One System is a molecular diagnostic platform developed to enable point-of-care testing for infectious diseases such as COVID-19. Click Here to get the full Stock Report for Talis Biomedical Corp stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App